Literature DB >> 1827816

IL-8 gene expression and production in human peripheral blood lymphocyte subsets.

M J Smyth1, C O Zachariae, Y Norihisa, J R Ortaldo, A Hishinuma, K Matsushima.   

Abstract

We have investigated IL-8 mRNA expression and IL-8 production in highly purified subsets of peripheral blood lymphocytes. T cells stimulated with PHA, ionomycin, or PMA alone failed to express IL-8 mRNA. However T cells stimulated with a combination of PMA and ionomycin or PMA and PHA expressed IL-8 mRNA in a PMA dose-dependent manner and maximally after 3 to 6 h of culture. Induction of IL-8 mRNA appeared to be specifically in the CD4+ T cell subset. Surprisingly, however, T cells were not induced to secrete significant levels of IL-8 polypeptide, even in the presence of accessory monocytes. In addition, immunoprecipitation analysis of PMA/ionomycin-treated T cell lysates detected only minor levels of cellular IL-8 Ag thereby suggesting that in T cells, the production of IL-8 was inhibited at the posttranscriptional level. By contrast, CD3- large granular lymphocytes (LGL) were both induced to express IL-8 mRNA and secrete biologically active IL-8 upon specific stimulation with IL-2 and ligand (anti-CD16 mAb) for the NK cell receptor for IgG-Fc (CD16), or upon nonspecific stimulation with PMA. IL-2 and anti-CD16 mAb synergistically induced IL-8 expression in LGL. Other nonactivating LGL-specific mAb did not induce LGL IL-8 secretion. The amount of IL-8 produced by activated LGL was donor variable, but generally 5 to 10 times less than that secreted by monocytes. The ability of LGL to release IL-8 and a large number of other cytokines further supports the hypothesis that LGL may contribute to both inflammatory and immunologic responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes.

Authors:  S Denault; M J April; J Stanková
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma.

Authors:  Baogang Zhang; Lihong Shi; Shijun Lu; Xiuning Sun; Yuqing Liu; Hongli Li; Xuejian Wang; Chunzhen Zhao; Heng Zhang; Ying Wang
Journal:  Cancer Biol Ther       Date:  2015-04-14       Impact factor: 4.742

3.  Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Authors:  Karen M Lammers; Sunaina Khandelwal; Fatima Chaudhry; Debby Kryszak; Elaine L Puppa; Vincenzo Casolaro; Alessio Fasano
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

4.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

5.  IL-8 is a mediator of NF-κB induced invasion by gliomas.

Authors:  Baisakhi Raychaudhuri; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-06-25       Impact factor: 4.130

Review 6.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

7.  Human T lymphocytes and T-cell lines as target cells for lymphocyte chemotaxis.

Authors:  C O Zachariae; K Kaltoft; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.

Authors:  Z M Dong; J W Murphy
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.

Authors:  L E DeForge; D E Tracey; J S Kenney; D G Remick
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

10.  Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions.

Authors:  C A Verburgh; M H Hart; L A Aarden; A J Swaak
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.